SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
This Quarter Return
+19.42%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$1.87B
AUM Growth
+$1.87B
(-9.8%)
Cap. Flow
-$395M
Cap. Flow
% of AUM
-21.13%
Top 10 Holdings %
Top 10 Hldgs %
40.72%
Holding
114
New
19
Increased
26
Reduced
20
Closed
11
Top Buys
| 1 |
Las Vegas Sands
LVS
|
$39.7M |
| 2 |
NVIDIA
NVDA
|
$32.8M |
| 3 |
Global Payments
GPN
|
$27.7M |
| 4 |
RH
RH
|
$27.4M |
| 5 |
TSMC
TSM
|
$23.9M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$73.2M |
| 2 |
Elevance Health
ELV
|
$67.7M |
| 3 |
Constellation Energy
CEG
|
$56.8M |
| 4 |
Estee Lauder
EL
|
$56.4M |
| 5 |
Colgate-Palmolive
CL
|
$54.4M |
Sector Composition
| 1 | Healthcare | 61.36% |
| 2 | Technology | 11.67% |
| 3 | Consumer Discretionary | 8.46% |
| 4 | Communication Services | 5.69% |
| 5 | Financials | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Spyre Therapeutics
SYRE
$996M
| $1.83M | 0.1% | 4,059,894 | – | – |
|
77
Gilead Sciences
GILD
$140B
| $1.75M | 0.09% | 22,700 | – | – |
|
78
Illumina
ILMN
$15.8B
| $1.64M | 0.09% | 8,730 | – | – |
|
79
IQVIA
IQV
$32.4B
| $1.61M | 0.09% | 7,175 | – | – |
|
80
Medtronic
MDT
$119B
| $1.54M | 0.08% | 17,460 | – | – |
|
|
81
Elevance Health
ELV
$71.8B
| $1.34M | 0.07% | 3,010 -152,311 | -98% | -$67.7M |
|
82
Stryker
SYK
$150B
| $1.33M | 0.07% | 4,360 +1,400 | +47% | +$427K |
|
83
argenx
ARGX
$43.6B
| $1.32M | 0.07% | 3,390 | – | – |
|
84
CVS Health
CVS
$92.8B
| $1.19M | 0.06% | 17,170 | – | – |
|
85
Cigna
CI
$80.3B
| $1.12M | 0.06% | 4,000 | – | – |
|
86
Intuitive Surgical
ISRG
$170B
| $1.05M | 0.06% | 3,070 +1,520 | +98% | +$520K |
|
87
Boston Scientific
BSX
$156B
| $987K | 0.05% | 18,241 | – | – |
|
88
Waters Corp
WAT
$18B
| $840K | 0.04% | 3,150 | – | – |
|
89
Avantor
AVTR
$9.18B
| $786K | 0.04% | 38,250 +22,850 | +148% | +$469K |
|
90
McKesson
MCK
$85.4B
| $782K | 0.04% | 1,830 | – | – |
|
91
DexCom
DXCM
$29.5B
| $756K | 0.04% | 5,880 | – | – |
|
92
Sarepta Therapeutics
SRPT
$1.78B
| $694K | 0.04% | +6,058 | New | +$694K |
|
93
Agilent Technologies
A
$35.7B
| $600K | 0.03% | 4,990 | – | – |
|
94
Idexx Laboratories
IDXX
$51.8B
| $462K | 0.02% | 920 | – | – |
|
95
United Therapeutics
UTHR
$13.8B
| $300K | 0.02% | 1,360 | – | – |
|
96
Edwards Lifesciences
EW
$47.8B
| $217K | 0.01% | +2,300 | New | +$217K |
|
97
Mettler-Toledo International
MTD
$26.8B
| $215K | 0.01% | 164 | – | – |
|
98
Charles River Laboratories
CRL
$8.04B
| $212K | 0.01% | 1,010 | – | – |
|
99
Bio-Techne
TECH
$8.5B
| $212K | 0.01% | +2,600 | New | +$212K |
|
|
OHAAW
100
DELISTED
OPY Acquisition Corp. I Warrant
OHAAW
| $10.9K | ﹤0.01% | 72,605 | – | – |
|